John M. Stuckey III - 01 May 2025 Form 4 Insider Report for CARMAX INC (KMX)

Role
SVP, Gen Counsel & Secretary
Signature
Christine Carter, attorney-in-fact
Issuer symbol
KMX
Transactions as of
01 May 2025
Net transactions value
-$24,683
Form type
4
Filing time
05 May 2025, 16:11:50 UTC
Previous filing
16 Jul 2024
Next filing
07 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stuckey John M III SVP, Gen Counsel & Secretary 12800 TUCKAHOE CREEK PARKWAY, RICHMOND Christine Carter, attorney-in-fact 05 May 2025 0002030154

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KMX Common Stock Options Exercise +1,228 +127% 2,197 02 May 2025 Direct F1
transaction KMX Common Stock Tax liability $24,683 -370 -17% $66.71 1,827 02 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KMX Stock Options (Right to Buy) Award $0 +20,968 $0.000000 20,968 01 May 2025 Common Stock 20,968 $65.52 Direct F2, F3
transaction KMX Restricted Stock Units Options Exercise $0 -1,579 -100% $0.000000 0 02 May 2025 Common Stock 1,228 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 0.7777 times the number of MSUs in shares of Company common stock.
F2 The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options.
F3 The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2026, May 1, 2027, May 1, 2028 and May 1, 2029.
F4 The restricted stock units vested on May 2, 2025 and were settled in Company common stock.